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ABSTRACT
Fentanyl is a potent opioid analgesic, which for decades has been used routinely in surgical and thera-
peutic applications. In addition to its analgesic properties, fentanyl also possesses anesthetic properties,
which are not well understood. Fentanyl is used in the general anesthesia process to induce and maintain
anesthesia in combination with the general anesthetic propofol, which fentanyl is known to potentiate. As
the atomic-level mechanism behind the potentiation of propofol is unclear, we have used classical molecu-
lar dynamics simulations to study the interactions of these drugs with the Gloeobacter violaceus ion chan-
nel (GLIC). This ion channel has been identified as a target for many anesthetic drugs. We identified
multiple binding sites using flooding style and Gaussian accelerated molecular dynamics (GaMD) simula-
tions, showing fentanyl acting as a stabiliser that holds propofol within binding sites. Our extensive GaMD
simulations were also able to show the pathway by which propofol blocks the channel pore, which has pre-
viously been suggested as a mechanism for ion channel modulation. General anesthesia is a multi-drug
process and this study provides the first insight into the interactions between two different drugs in the
anesthesia process in a relevant biological environment.
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1. Introduction
The phenomenon of general anesthesia is a medically
induced loss of consciousness which renders the patient
immobile and non-responsive to painful stimulus, thereby
allowing invasive surgical procedures to be performed under
the safest possible conditions. The discovery of molecules
which possess properties that induce anesthesia has caused
significant advances within the field of medicine, but to date
a lack of understanding remains of the molecular mecha-
nisms which lead to general anesthesia. Early investigations
into the mechanisms of anesthesia were carried out by
Meyer (Meyer, 1899) and Overton (Overton, 1901) who pro-
posed a lipid-mediated mechanism due to the correlation
between the solubility of anesthetic molecules in oil and
their potency. Consequently, studies have been performed
on a large range of anesthetic molecules in different solvent
environments, (Johansson & Zou, 1999; Taheri et al., 1991)
which have followed the hypothesis laid down by Meyer and
Overton, but several exceptions have been identified.
(Cardoso et al., 1999; Fang et al., 1997; Koblin et al., 1995,
1994; North & Cafiso, 1997) Several studies have proposed
that anesthetics cause alteration of specific membrane prop-
erties, such as the lateral pressure profile, which will affect
membrane proteins whose function depends on a transition
between conformational states that is accompanied by a
depth-dependent change in cross sectional area. (Cantor,
1999; van den Brink-van der Laan et al., 2004) The specific
locations adopted by anesthetics within the cellular mem-
brane have also been investigated by Pohorille et al., who
proposed that anesthetics reside at the lipid-water interface.
(Pohorille et al., 1998) Although there is a wealth of pub-
lished work examining the role of the lipid membrane, the
main theory which has attracted the most attention in recent
years is the direct binding of anesthetics to pentameric lig-
and-gated ion channels (pLGICs) or cys-loop receptors.
pLGICs are of vital importance to life as they are responsible
for converting synaptic chemical signals into electrical
impulses within the peripheral and central nervous systems
(Corringer et al., 2012) and as such they are targets for gen-
eral anesthetics. (Campagna et al., 2003; Hemmings et al.,
2005) Prokaryotic homologues of pLGICs have provided
high-resolution crystal structures such as those from
Gloeobacter violaceus (GLIC). (Bocquet et al., 2009; Hilf &
Dutzler, 2009) Crystal structures of GLIC have also been iden-
tified that show binding of various general anesthetics,
including ethanol, (Sauguet et al., 2013) ketamine, (Pan et al.,
2012) desflurane, (Nury et al., 2011) and propofol, (Fourati
et al., 2018; Nury et al., 2011) to the extracellular and trans-
membrane domains of the protein structure. These discov-
eries have provided the strongest evidence thus far that
anesthetics exert their main function by modulating the
activity of these ion channels.
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The Gloeobacter violaceus ion channel is a pentameric lig-
and-gated ion channel which is composed of five identical
subunits (S1 - S5) forming a homopentameric ion channel,
where each subunit possesses an extracellular domain (ECD)
and a transmembrane domain (TMD). The TMD of each sub-
unit consists of four a-helices (M1 - M4) which span the
entirety of the phospholipid membrane in which the GLIC is
inserted. The M2 a-helices are orientated towards the center
of the pore which forms the ion-conducting channel. This is
illustrated in Figure 1. Propofol is an intravenous general
anesthetic, which is widely used to induce and maintain gen-
eral anesthesia, often in combination with the opioid anal-
gesic fentanyl, (Bajwa et al., 2010; Bell et al., 1994; Todd
et al., 1993) as it facilitates rapid and safe anesthesia with
stable hemodynamics and relatively few negative side
effects. The role of fentanyl is to provide the analgesic com-
ponent to the general anesthesia process, although fentanyl
does possess anesthetic properties itself and has been used
as the main component in general anesthesia. (Sebel et al.,
1981; Stanley & Webster, 1978) Fentanyl has also been
shown to potentiate the anesthetic effect of propofol, (Vuyk,
1997; Lichtenbelt et al., 2004; Smith et al., 1994) but know-
ledge of the specific interactions between propofol and fen-
tanyl at the molecular level is lacking. Understanding the
interactions between these drugs at their site of action, how-
ever, could lead to further development of safer and more
efficient anesthetic drugs which will reduce the risk of anes-
thesia-related complications and help uncover the mecha-
nisms behind this phenomenon.
In this paper we utilise two enhanced sampling molecular
dynamics (MD) simulation techniques, namely conformational
flooding and Gaussian accelerated molecular dynamics
(GaMD), to probe the interactions between fentanyl and pro-
pofol at the GLIC channel. GLIC was chosen for study as sev-
eral structures have been published that show propofol
binding, (Fourati et al., 2018; Nury et al., 2011) and we pro-
pose that fentanyl could also act in this channel in combin-
ation with propofol. To the best of our knowledge, no MD
simulations have been performed on this combination of
drug molecules with GLIC. From our simulations we were
able to identify multiple sites in GLIC where both drug mole-
cules appear to act and alter the protein mobility and
flexibility.
2. Materials and methods
2.1. System preparation and MD simulations
All systems prepared for the MD simulations were based on
the high-resolution open-state crystal structure (PDB: 4HFI) of
GLIC. (Sauguet et al., 2013) The structure was embedded in a
DOPC lipid bilayer and fully hydrated with TIP3P (Jorgensen
et al., 1983) water using the CHARMM-GUI web server (Jo
et al., 2008; Wu et al., 2014) and data from the orientation of
proteins in membranes (OPM) database. (Lomize et al., 2012)
DOPC was chosen as it was used previously by the publish-
ers of the crystal structure. (Sauguet et al., 2013) Each system
has the approximate dimensions of 128 130 x 180Å where
the z-axis is normal to the bilayer, and contains 1 GLIC, 307
DOPC lipids, and 54,000 water molecules. Sodium and
chloride ions were added to give a 150mM salt concentra-
tion. 50 propofol and 10 fentanyl were added to the aque-
ous solution for the flooding and GaMD simulations. Each
system contained 230,000 atoms.
Protonation states of the ionisable residues of the protein
were assigned based on the calculations performed by
Bocquet et al. (Bocquet et al., 2009) Parameters and atomic
point charges for each drug molecule were assigned using
the antechamber program which is freely available with
AmberTools program, and is compatible with the General
Amber ForceField (GAFF) (Wang et al., 2004) for small
organic molecules.
All MD simulations were performed using the CUDA
enabled Amber16 (Case et al., 2016) molecular dynamics
package. The ff14SB forcefield (Maier et al., 2015) was used
for the protein, solvent and ions, the lipid14 forcefield
(Dickson et al., 2014) was used for the lipids and the GAFF2
forcefield (Wang et al., 2004) was used for the drug mole-
cules. The systems were energy minimised for 20,000 steps
(10,000 steepest descent then 10,000 conjugate gradient).
Heating was conducted in two stages, where stage 1
involved heating the system to 100 K in the NVT ensemble
with the protein, lipids and drug molecules restrained with a
force constant of 10.0 kcal/mol Å2. Stage 2 involved heating
the system slowly to 303 K in the NPT ensemble, again with
the protein, lipids and drugs restrained with a force constant
of 10.0 kcal/mol Å2. Equilibration was performed initially with
multiple 2 ns simulations where the lipid restraints were
gradually reduced from 10 to 0 kcal/mol Å2 over 22 ns. This
procedure was then repeated while reducing restraints on
the protein backbone totalling another 22 ns (44 ns in total).
The unrestrained conformational sampling simulations were
run for 1 ls and the GaMD simulations were run for 500 ns.
3 repeats for each method were carried out. One simulation
was carried out on the pure GLIC structure as a control to
determine if the system was constructed correctly, which
was run for 500 ns. All simulations were carried out at a con-
stant pressure of 1.0 atm, which was maintained using the
anisotropic Berendsen method with a pressure relaxation
time of 1.0 ps. The temperature was maintained at 303 K
using the Langevin thermostat with a collision frequency of
c¼ 1.0 ps– 1. Three-dimensional periodic boundary conditions
with the usual minimum image convention were used. The
SHAKE algorithm was employed to constrain covalent bonds
to hydrogen, allowing the use of a 2 fs time step.
Electrostatic interactions were treated with the PME method
using a cutoff of 10 Å. Data analysis was carried out using
VMD, (Humphrey et al., 1996) CPPTRAJ (Roe & Cheatham,
2013, 2018) and in house scripts. Images were rendered
using UCSF Chimera (Pettersen et al., 2004) and VMD.
(Humphrey et al., 1996)
2.2. Flooding simulations
Simulation studies on the GLIC system in the past have
mostly focused on the anesthetic binding site from the pub-
lished crystal structure, (Nury et al., 2011) which often
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involved docking the drug molecule within the observed
site. However, this methodology does not take into account
the pathway of the drug molecule, or any other binding sites
that can be occupied. We have investigated the possibility of
these alternative binding sites and pathways by implement-
ing three independent 1 ls flooding simulations in which 50
propofol molecules and 10 fentanyl molecules were added
to the solvent phase of the last frame of the pure GLIC con-
trol simulation, which was used as the starting structure; this
methodology is similar to other studies conducted on differ-
ent anesthetics. (Arcario et al., 2017; Brannigan et al., 2010)
The drug molecules were added to the system at random
initial positions using the gmx insert-molecules tool available
with the GROMACS package. (Van Der Spoel et al., 2005)
Propofol was used in excess in our simulations to mimic the
higher concentration of propofol in the general anesthesia
process. We note that the ratio of opioid to anesthetic is
higher here than would be used in surgery, but the goal of
using a higher ratio is to increase the probability of finding a
site of opioid-anesthetic interaction during the simulations.
The MD flooding approach provides a dynamic, flexible and
physical dock which is a significant advantage over trad-
itional docking procedures. (Brannigan et al., 2010; Raju
et al., 2013)
2.3. Gaussian accelerated molecular dynamics
GaMD is an accelerated MD method which allows uncon-
strained sampling and accurate reconstruction of the free-
energy profiles, thereby allowing long timescale events
which would normally occur over hundreds of microseconds
to milliseconds to be probed in more realistic simulation
times. (Miao & McCammon, 2017; Palermo et al., 2017) A full
mathematical description of the methodology can be found
in the original publication (Miao et al., 2015) and only a brief
description will be given here. The enhanced conformational
sampling provided by GaMD is obtained by adding a har-
monic boost potential which reduces the energy barriers in
the system. When the total system potential V( r
*
) is lower
than the reference energy E, the new potential V( r*) of the
system is calculated as:
Vð r*Þ ¼ Vð r*Þ þ DVð r*Þ (1)
DVð r*Þ ¼
1
2 kðEVð r
*ÞÞ2, Vð r*Þ < E
0, Vð r*Þ  E,
8<
: (2)
where k is the harmonic force constant. The two adjustable
parameters E and k are automatically determined based on
three principles. First, for any two arbitrary potential values
VA( r
*
) and VB( r
*
) found on the initial energy surface, if VA( r
*
)
< VB( r
*
), DV should be a monotonic function which allows
the relative order of the biased potential to remain constant.
Second, if VA( r
*
) < VB( r
*
), then the potential difference on
the flattened energy surface should be smaller than that of
the original. By a combination of the first two principles, we
obtain:
Vmax  E  Vmin þ 1=k, (3)
where Vmin and Vmax are the system minimum and maximum
potentials. The standard deviation of DV has to have a narrow
distribution, so accurate re-weighting by cumulant expansion to
the second order can be performed: rDV ¼ k(E - Vavg)rV  r0,
where Vavg and rV are the average and standard deviation of
the system potential energies. rDV is the standard deviation of
DV and r0 is a user-specified upper limit for accurate
re-weighting.
We have carried out extensive tests to obtain suitable
parameters for our systems. The system threshold energy
was set to E¼Vmax for all GaMD simulations. The dual-boost
scheme was used, in which an acceleration potential is
applied to the torsional terms and to the entire system
potential. Vmax, Vmin, Vavg and rV were obtained from an ini-
tial 8 ns NPT simulation without boost potential. Each GaMD
simulation then underwent a 40 ns run in which the boost
potential was updated every 1.6 ns, thus reaching
Figure 1. (A) Graphical representation of the transmembrane a helical domains showing the 5 symmetric subunits and the ion conducting M2 helices (red). (B)
GLIC structure in the membrane environment, some lipids removed for clarity of TMD.
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equilibration values. Production runs were carried out for
500 ns for all three simulations, in which each was started
with random particle velocities. The same number of drug
molecules as in the flooding simulations were included in
the GaMD simulations. Trajectory frames were saved
every 1 ps.
3. Results and discussion
3.1. Flooding
Almost instantly during the production runs, both drug mol-
ecules begin to partition into the membrane (Figure 2), often
forming small clusters in which multiple propofol molecules
bind to one fentanyl molecule. To assess the structural stabil-
ity of the GLIC structure within the membrane, the root
mean squared deviation (RMSD) of the backbone of the pro-
tein was calculated to be less than 3.0 Å over the full length
of the simulations and the average RMSD was
1.922 ± 0.209Å, based on which the simulations were
deemed to be stable as the protein remained in its native
structure. Multiple binding regions were identified for propo-
fol, where protein residues interacted with the anesthetic for
several ns of the simulation. Of these potential interaction
sites, only one was observed over multiple subunits for sev-
eral hundred ns. This interaction site was located in the
transmembrane domain (TMD) close to the experimentally
identified site, see Figure 3. The other sites, where shorter
interactions were observed, most likely represent non-specific
adhesion of propofol to the protein surface rather than a
functional binding site. The site where most stability is
observed is identical to that observed in a study carried out
by Arcario et al., (Arcario et al., 2017) in which they observed
desflurane binding to GLIC by forming a hydrogen-bond to
Tyr-254 during their simulations. The stability associated with
propofol at this site (Figure 3B) is due to the formation of a
hydrogen-bond between the hydrogen of the Tyr-254
hydroxyl group and the oxygen of the propofol hydroxyl
group, which was calculated for the propofol interacting at
subunit 3. The hydrogen-bond remains dominant over the
full time in which the propofol molecule remains stable,
which is approximately 400 ns. This stability was shown by
calculating the distance between the propofol molecules
observed to interact at this site in each subunit, and the cen-
ter of mass (COM) of the experimental anesthetic binding
site, in which propofol has been shown to bind. (Nury et al.,
2011) The S3 propofol remains bound from  200 ns to 
650 ns, where the hydrogen-bond to Tyr-254 contributes to
propofol’s overall stability here. Three propofol molecules
were observed to bind to the same site at the same time,
and this asymmetric ligand binding has been shown to play
a role in channel function. (Mowrey et al., 2013) Our distance
calculations have shown that this binding site holds the pro-
pofol molecules at  10Å from the deeper transmembrane
site, indicating a possible transition pathway, although this
was not observed to happen in any of our simulations.
Throughout the flooding simulations, multiple bound anes-
thetics were observed at multiple subunits which helps to
explain why large amounts of general anesthetic are required
to induce the desired clinical effect. This observed behaviour
strengthens the argument that these drugs indiscriminately
bind to several targets. (Eckenhoff et al., 2002; Harrison,
2000; Herold & Hemmings, 2012)
An interesting observation made during our flooding sim-
ulations was propofol occupying the exact same binding site
in the extracellular domain that the general anesthetic keta-
mine has been shown to occupy. (Pan et al., 2012) This site
is approximately 10 Å below the orthosteric agonist-binding
site in the extracellular domain. Ketamine binding in this site
was also shown to modulate the function of the GLIC chan-
nel. (Ion et al., 2017) Previously identified sites for propofol
were located in the upper transmembrane domain within a
subunit (Nury et al., 2011) which is very different from that
identified for ketamine, which is located  10Å below the
orthosteric agonist-binding site. We observed propofol bind-
ing in this extracellular site within the first 100 ns of simula-
tion and it remains in this site for the rest of the 1 ls
simulation, totalling  900 ns of residence time within the
site. Propofol remains fairly mobile within the site with a
RMSD of 5.0 ± 1.4 Å, which is due to the relatively small
molecular volume of propofol ( 191 Å3) compared to the
ketamine site ( 248 Å3) The residues within 4Å of propofol
displayed a RMSD of 1.7 ± 0.5 Å, which shows that the struc-
ture in this flexible loop region is fairly resilient to propofol
binding. Identification of multiple binding sites presents a
compelling case for the allosteric action of molecules which
possess anesthetic properties.
3.2. GaMD
Our GaMD simulations were able to capture complete binding
of one propofol molecule into the channel pore just above the
hydrophobic gate region. Binding was captured within  50ns
in all three independent GaMD simulations, whereas this bind-
ing mode was not observed in any of our 1 ls flooding simula-
tions. We found that propofol diffuses from the bulk solvent to
the b-3 loop in the upper extracellular domain of subunit one,
before moving to the b-8 loop between subunits one and two
in the extracellular domain, and finally into the center of the
M2 pore above the Ile-239 gating residues, see Figure 4B. By
aligning the C-terminal domain of the GLIC, the RMSD of the
diffusing propofol molecule relative to its position in the pore
in the last simulation frame reaches a minimum of 1.1Å. It
forms hydrophobic interactions with several residues around
the pore opening, see Figures 4A and C.
The boost potential applied during the GaMD simulations
follows a Gaussian distribution and its distribution anhar-
monicity c equals to 1.94 10– 2. The average and standard
deviation of DV are 15.3 kcal/mol and 4.7 kcal/mol, respect-
ively. Such narrow distribution will ensure accurate re-
weighting for the free energy calculations using cumulant
expansion to the 2nd order. Using the RMSD of propofol rela-
tive to the final frame pose and the number of protein heavy
atoms that are within 5Å of propofol (Ncontact), a 2 D poten-
tial of mean force (PMF) profile was calculated by re-weight-
ing the three 500 ns GaMD simulations using the
PyReweighting toolkit. (Miao et al., 2014) As the pore
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blocking pathway was observed in all three replicates, the
data were combined to produce the PMF in Figure 4A. The
re-weighted PMF allows us to identify four low-energy states:
the unbound (”U”), intermediate 1 (”I”), intermediate 2 (”II”)
and bound (”B”) states. The maximum energy was capped at
15 kcal/mol for clarity in identifying relevant states. The
unbound state is located in a local energy well centred at
(10, 60 Å), the intermediate 1 state is centred at (50,
40Å), the 2nd intermediate state is centred at (20, 20Å)
and the bound state is located at the global energy min-
imum (60, 0 Å). We should note here that propofol binding
within the M2 helix pore was observed in all three 500 ns
GaMD simulations, so we can assume that calculated ener-
gies between individual states have a low degree of error
due to limited sampling. Propofol forms hydrogen-bonds
within the channel pore with residues Thr-236, Thr-1480, Thr-
858 and Thr-1169 (Figure 4C). Hydrogen-bonds are also
formed along the pathway to the pore with residues Ile-854,
Arg-1345, Asn-1319 and Glu-1305.
Anesthetic transmembrane binding site
Most studies conducted on this system focus on the binding
site which was observed in the original crystal structure,
(Nury et al., 2011) for example using docking methods. To
Figure 2. (A) First and (B) final frame of 1 ls of production simulation. Blue represents fentanyl and red represents propofol.
Figure 3. (A) Distance between interacting propofol molecules and COM of experimental binding site. (B) Snapshot showing the binding site in which propofol (lic-
orice representation) interacts with Tyr-254 (licorice representation) and Asn-307 (yellow). The anesthetic binding site residues are shown; Tyr-193 (green), Ile-202
(blue), Met-205 (red), Val-242 (orange), Thr-255 (pink) and Ile-259 (blue). M1-M4 are the transmembrane helices located in each subunit. Hydrogen-bond between
propofol and Tyr-254 shown by green dashed line.
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assess whether any propofol molecules in our GaMD simula-
tions entered this site, we defined the binding site by the
following residues: Tyr-193, Ile-198, Met-201, Val-238, Thr-251
and Ile-255. We used the center of mass (COM) of these
binding site residues and computed the distance between
this COM, and any propofol molecules which were identified
as being close to the subunit by visual inspection in VMD.
(Humphrey et al., 1996) During the calculations, a step size
of 10 was used. Figure 5 shows the distances of the identi-
fied propofol molecules to the anesthetic transmembrane
binding site. No molecules were identified for S2. Figure 6
shows multiple molecules competing at S1, although we
notice that none of the molecules get close to the binding
site. Stable regions are located between 10 and 20Å from
the experimentally observed site. We initially suspected that
this distance was due to the propofol molecules interacting
with each other and forming a small cluster, as was observed
in our previous work. (Faulkner et al., 2020) Upon further
investigation we observe this same distance for subunits S3
and S4 in which only one molecule has stable distances
between 10 and 20Å, which rules out the hypothesise that
this is caused by intermolecular interaction. The data shown
in Figure 5 were taken from one replicate in which the most
interactions were observed. When we investigate the site at
which the propofol molecules are stable, we observe a site
formed by residues Phe-261, Phe-295 and Val-264 (Figure 6B).
These residues block the passage of the propofol molecules
into the upper region of the transmembrane domain. The Phe
residues form p-p interactions with each other and the propofol
molecule, which contributes to the stability observed here. If
we are to take the crystal structure binding site as true, we
must assume that longer time scales are required to observe
binding, or an allosteric mechanism in which another binding
site has to be occupied to allow passage of propofol through
the Phe-261 Phe-295 site into the crystal binding site, although
none of this was observed in 3 ls of cMD and 1.5 ls of GaMD.
We should note here that no propofol molecules were
observed to enter from the other side of the M4 helix (between
M4 and M1). To investigate the dynamical consequences on
GLIC induced by the drug molecules, we computed the dis-
tance between Asp-32 and Arg-192 which form a salt bridge. It
has been suggested that salt bridge perturbation is important
for channel functions; this was shown in a nAChR channel, (Xiu
et al., 2005) and a GLIC where the volatile anesthetic halothane
caused disruption of this salt bridge, which led to instability
within the channel. (Chen et al., 2010) We did observe for mul-
tiple subunits, where drug molecules were present, that this
salt bridge did not hold.
Figure 4. GaMD simulations captured pore binding of propofol: (A) 2 D (Ncontact, propofol RMSD) PMF calculated by reweighting the 500 ns GaMD simulation. (B)
Pathway of propofol diffusion into the M2 helix pore in all three GaMD simulations. (C) Hydrogen-bonds formed between propofol and the GLIC, where bonds
formed after 10000 steps are in the pore. Protein refers to short lived hydrogen-bonds formed on the protein exterior. Data combined from all three replicates. (D)
Final frame snapshot showing propofol hydrogen-bonding to Thr-236 in S1.
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To determine whether fentanyl and propofol share bind-
ing sites, we constructed density maps using the VOLMAP
VMD plugin. (Humphrey et al., 1996) These density maps,
shown in Figure 7, were averaged over the whole simulation
trajectories, apart from the first 50 ns which were discarded
for system equilibration. Identified regions of high density
therefore reflect locations, where drug molecules resided for
a prolonged period of time. Density maps were computed
Figure 5. Calculated distances between the binding site COM and identified propofol molecules. Each line in the graphs represents a propofol molecule.
Figure 6. Interaction site of propofol at GLIC subunits: (A) Sites of propofol interaction in relation to the anesthetic binding site in which residues are coloured; Tyr
(green), Ile (blue), Met (red), Val (orange), Thr (pink) and His (yellow). Propofol molecules are shown in licorice representation. (B) Blocking residues inhibiting the
path to the anesthetic binding site, propofol (violet) shown in licorice representation.
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for both the cMD flooding simulations and the GaMD simula-
tions, which allowed us to determine if the accelerated simu-
lations were able to discover binding sites which are
unattainable from conventional simulations. The main differ-
ence that we observed between the classical molecular
dynamics flooding simulations and the GaMD simulations is
the occupation of the ion channel pore by propofol, which
was observed in all 3 GaMD simulations. The pore is occu-
pied by one propofol molecule which resides above the
hydrophobic gating Ile-239 residues that form the top of the
hydrophobic gate in GLIC (Zhu & Hummer, 2010). The mol-
ecule is mobile within the pore with a RMSD of 6.06 ± 0.76 Å.
This propofol molecule blocks the majority of the pore,
which disrupts the flow of water molecules through the
pore. As stated, the pore-blocking molecule is mobile within
the pore, where it mostly forms hydrogen-bonds with the
threonine residues located at the top of the M2 helices.
Hydrogen-bonding calculations show that these residues
form the majority of the hydrogen-bonding interactions
within the pore (Figure 4C). Only one propofol molecule was
found to block the pore in each GaMD simulation. The gen-
eral anesthetic isoflurane has been shown to block the pore
of GLIC and nAChR as a dimer, (Brannigan et al., 2010) but
this behaviour was not observed for propofol in any of our
simulations, most likely due to the larger size of propofol
compared to isoflurane. LeBard et al. (LeBard et al., 2012)
predicted the physical blocking of the pore in GLIC by pro-
pofol, which was shown to bind to the pore with high affin-
ity, as calculated from free energy perturbation (FEP)
calculations. They predicted that propofol would bind as a
dimer in a similar fashion to isoflurane, but we did not
observe this in around 5 ls of conventional and Gaussian
accelerated MD simulations. A structure of propofol bound
to the pore of GLIC has not been resolved experimentally,
most likely due to the binding of detergents (dodecylmalto-
side, DDM) within the pore. (Bocquet et al., 2009; LeBard
et al., 2012)
Our GaMD simulations allowed us to identify the pathway
by which propofol binds to the channel pore, Figure 8 shows
the sites associated with the intermediate states calculated
from the reweighted GaMD simulations. The first intermedi-
ate state of the propofol binding pathway is located in the
b3 loop region at the top of the extracellular domain, where
propofol forms short-lived hydrogen-bonds to the glutamic
acid residues before moving to the second intermediate
state. This second binding state is located between the b1-
Figure 7. Regions of prolonged occupation by propofol (red) and fentanyl (blue) in the GLIC. (A and B) represent the TM and EC domains of the GLIC, respectively,
from the GaMD simulations. (C and D) represent the TM and EC domains of the GLIC, respectively, from the cMD flooding simulations.
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b2 loop and the b4-b5 loop in the inner region of the extra-
cellular vestibule, where propofol remains for 36 ns before
diffusing into the M2 helix pore to remain there for the rest
of the simulation. Propofol molecules that were observed to
bind near the transmembrane intra-subunit anesthetic bind-
ing site displayed interesting dynamics within the binding
site during the GaMD simulations, where the molecule
would” hop” from one intra-subunit site to the adjacent
intra-subunit site. Propofol was observed to traverse through
a binding tunnel between the M3 helix of one subunit and
the M1 helix of the adjacent subunit into an inter-subunit
site initially, then into the intra-subunit site (Figure 9). We
also observed multiple occupancy in transmembrane sites
where up to three propofol molecules occupied an intra-sub-
unit site. This multiple occupancy was initiated by small clus-
ters of propofol molecules forming within the lipid bilayer
region and then diffusing towards the TMD where they then
bind to the TMD helices. Fentanyl was not observed to bind
within the channel pore; We have previously shown that
fentanyl binds to an inter-subunit site in the extracellular
domain, (Faulkner et al., 2019) when propofol is not present. In
this study we observe sites where fentanyl shares a binding site
with propofol, mostly shown in our flooding simulations in the
extra-cellular domain (Figure 7D). In the extra-cellular domain
we initially observe several propofol molecules interacting with
a single fentanyl molecule, before this cluster moves towards
the extra-cellular region of the ion channel, where several pro-
pofol molecules diffuse away from the fentanyl molecule and
the remaining propofol molecule forms a very stable hydrogen-
bond with Asp-1418 located on loop C (Figure 10C). This hydro-
gen-bond remains stable for the majority of the simulations,
where the fentanyl molecule remains located beside the propo-
fol molecule, which we believe acts as a stabiliser for the bound
propofol which has an RMSD of 2.04±0.4Å. Table 1 shows the
RMSD values for propofol when bound to Asp-1418, before
and after the interaction with fentanyl. We can see that there is
a stabilisation effect on propofol when fentanyl is present at
the binding site. When we look at the flexibility of loop C,
Figure 8. Graphical representations of the intermediate states of propofol (green sticks) calculated from reweighted GaMD simulations. Contact residues shown
explicitly in stick representation.
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where propofol binds (Figure 10C), we see that the flexibility is
almost identical to the pure structure when fentanyl is present.
When only propofol binds here, we see that the flexibility of
this region increases significantly. This shows that fentanyl not
only stabilises the propofol molecule, but also a structurally
important section of the GLIC extracellular region. We also
analysed the flexibility of the cys-loop (Figure 10A) in the pure
system and compared it to the systems in which propofol and
fentanyl are bound. The cys-loop is thought to be a crucial
component in the gating of pLGICs, (Cederholm et al., 2009;
Nys et al., 2013; Schofield et al., 2003) and in our analysis we
can clearly see the increased mobility of the cys-loop (Figure
Figure 9. (A) Graphical representation of the propofol subunit hopping pathway in the TMD. (B) RMSD plot showing the change in position of propofol from the
initial site (1) to the intermediate, intersubunit site (I) and then to the adjacent intrasubunit site (2). Reference for the RMSD calculation was taken from propofol in
site 1. Data shown from one trajectory.
Figure 10. (A) Structure of one subunit highlighting key areas of the protein. (B) Cys-loop RMSD plot for pure and drug-bound systems. (C) p-p interaction of the
fentanyl N-phenyl-propanamide ring and the propofol aromatic ring and the hydrogen-bond between propofol and Asp-1418 on loop C.
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10B) when the drug molecules are bound. This shows that the
combination of these drug molecules could play a role in mod-
ulating the channel function. The backbone of the fentanyl
molecule remains flexible throughout the simulations, but the
N-phenyl-propanamide ring remains at an 90 angle to the
aromatic ring of propofol, forming a proposed p-p interaction
to stabilise the propofol in this site. From the density maps
(Figure 7) we can see that there is overlap of the two drugs in
the transmembrane domain, as well as in the extracellular
domain. Within the TM domain we observe similar interactions
as those shown in Figure 10C, where fentanyl forms p-p inter-
actions with propofol and holds it in a specific site. The trans-
membrane sites where we observe these interactions are
located near the bottom of the M2 helices, close to the
phospholipid headgroup region. The fentanyl molecules stabil-
ise the propofol molecule in the lower M2 intra-subunit site
before diffusing to the next subunit. This behaviour was
observed in both the flooding style simulations and the GaMD
simulations.
4. Conclusions
In this study we have applied flooding style and Gaussian
accelerated molecular dynamics simulations to study how
the general anesthetic propofol and the opioid analgesic/
anesthetic fentanyl interact with the GLIC channel. Our
GaMD simulations reveal a detailed pathway for the pore-
blocking mechanism by propofol, which has not been
observed previously using conventional MD simulation meth-
odologies. The GaMD simulations also showed that propofol
is able to hop between transmembrane intra-subunit binding
sites by diffusing through a binding tunnel formed by helices
of the occupied and adjacent transmembrane subunits.
Fentanyl was shown to play an important role in the stabil-
isation of propofol molecules in several binding sites. Initial
interactions between fentanyl and propofol lead to the accu-
mulation of a small number of propofol molecules with a
fentanyl molecule. This small cluster either diffuses rapidly
into the membrane region where most propofol molecules
leave the fentanyl, with one remaining propofol binding to
the transmembrane domain of GLIC where fentanyl acts as a
stabiliser. The other propofol molecules, diffuse towards the
extracellular domain of GLIC, binding close to the orthosteric
agonist-binding site, where we again observe ligand stabilisa-
tion by fentanyl. The results presented here show the first
evidence of the opioid fentanyl interacting with, and altering,
propofol binding in GLIC. The structural results of propofol
and fentanyl interacting at GLIC present a compelling case
for the allosteric action of anesthetics and opioids at pLGICs.
We consider that this study, along with our previous work,
(Faulkner et al., 2019) calls for a comprehensive examination
of the role of the opioid in the general anesthesia process.
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